Skip to content
Trial Eligibility
Menu

Accelerated Resolution Therapy for Early Maladaptive Grief

NCT05624879

This study is recruiting at 4 US sites in 3 states, according to its ClinicalTrials.gov record last updated .

Summary

The purpose study is to test the effects of accelerated resolution therapy (ART) on pre-loss grief and prolonged grief disorder among older adult family caregivers (FCGs). Additionally, to better understand predictors of response to ART, and cognitive processes that occur among grieving individuals following ART.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Grief

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
60 years and older
Sex
All
Healthy volunteers
Accepted
Sponsor
Mayo Clinic
Last updated on ClinicalTrials.gov
September 25, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Arizona · 1

  • Mayo Clinic Arizona · Phoenix, AZ

Florida · 2

  • Suncoast Hospice · Clearwater, FL
  • Mayo Clinic Florida · Jacksonville, FL

Minnesota · 1

  • Mayo Clinic · Rochester, MN

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.